ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs MXN
20.0779
-1.33%
Brent Oil
72.72
0.46%
Bitcoin
97,755.12
0.30%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Australia
  5. ASX
  6. CSL Limited (CSL)

  7. CSL Limited (CSL) Noticias

CSL

CSL (CSL)

CSL Limited
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:ASX:CSL
FechaHoraFuenteTítuloSímboloCompañía
02/05/202311:44Dow Jones NewsTravere Therapeutics Shares Touch 52-Week Low on FSGS Study DataASX:CSLCSL Limited
02/11/202210:34Dow Jones NewsArcturus Therapeutics Shares Rise 31% After Vaccine CollaborationASX:CSLCSL Limited
01/11/202218:27Dow Jones NewsArcturus Up 26% After Hours on CSL Seqirus Vaccine CollaborationASX:CSLCSL Limited
14/12/202102:54Dow Jones NewsVifor Pharma Surges Again as Board Recommends CSL Bid Valuing Equity at $11.7 BillionASX:CSLCSL Limited
14/12/202101:00Dow Jones NewsCSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- 2nd UpdateASX:CSLCSL Limited
14/12/202100:49Dow Jones NewsCSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- UpdateASX:CSLCSL Limited
14/12/202100:24Dow Jones NewsCSL Makes US$11.7 Billion Offer for Switzerland's Vifor PharmaASX:CSLCSL Limited
12/12/202118:49Dow Jones NewsCSL in Talks With Vifor Pharma Over Potential TransactionASX:CSLCSL Limited
10/12/202018:57Dow Jones NewsCovid-19 Vaccine Candidate Scrapped After False Positives on HIV TestsASX:CSLCSL Limited
06/09/202018:06Dow Jones NewsCSL Signs 2 Initial Agreements for Coronavirus Vaccine SupplyASX:CSLCSL Limited
19/08/202004:46Dow Jones NewsCoronavirus Pandemic Slashes Donations of Lifesaving PlasmaASX:CSLCSL Limited
09/12/201908:12Dow Jones NewsCSL Bering Gets FDA Orphan Designation for HizentraASX:CSLCSL Limited
14/05/201908:20Dow Jones NewsHaemonetics Cuts Guidance on CSL Plasma DealASX:CSLCSL Limited
23/10/201807:58Dow Jones NewsSeqirus Gets FDA Approval for Afluria Quadrivalent in Young ChildrenASX:CSLCSL Limited
01/12/201605:05NewspaperShould you buy Australian Foundation Investment Co Ltd?ASX:CSLCSL Limited
27/07/201602:32Dow Jones NewsAustralia Stocks Close Near Flat After Mixed Inflation DataASX:CSLCSL Limited
26/07/201602:14Dow Jones NewsAustralia Stocks End up Slightly as Key Inflation Data LoomsASX:CSLCSL Limited
15/10/201518:37Dow Jones NewsCSL Catches Cold from Flu Vaccines Deal with Novartis -- Market TalkASX:CSLCSL Limited
16/08/201521:19Dow Jones NewsIs A$100 a Share Cursed? -- Market TalkASX:CSLCSL Limited
04/08/201503:18Dow Jones NewsAustralian Shares End Higher, Helped by Earnings and Sales DataASX:CSLCSL Limited
28/07/201503:28Dow Jones NewsAustralia Shares End Slightly Down; Energy Stocks RiseASX:CSLCSL Limited
22/04/201518:20Dow Jones NewsCSL Says CFO Naylor to Lead Influenza-Vaccine BusinessASX:CSLCSL Limited
16/03/201522:01The Motley FoolWhat do rising U.S. interest rates mean for Australian companies? ASX:CSLCSL Limited
10/02/201523:54Dow Jones NewsCSL Shaves Guidance as Competition Heats Up-- UpdateASX:CSLCSL Limited
03/12/201406:18Dow Jones NewsDrooping Commodities Hurt Down Under -- Barron's AsiaASX:CSLCSL Limited
26/10/201421:31Dow Jones NewsCSL to Buy Novartis Influenza-Vaccine UnitASX:CSLCSL Limited
26/10/201417:49Dow Jones NewsCSL to Buy Novartis Influenza-Vaccine Unit for $275 MillionASX:CSLCSL Limited
24/01/201401:22Dow Jones NewsAustralia Shares End Lower on China Growth Concerns, DataASX:CSLCSL Limited
13/01/201406:20Dow Jones NewsU.S. Stock Futures Are LowerASX:CSLCSL Limited
12/01/201418:44Dow Jones NewsS&P/ASX 200 Down 0.2% in Quiet TradeASX:CSLCSL Limited
 Showing the most relevant articles for your search:ASX:CSL

Su Consulta Reciente

LATK
LEPAUSDT
Lepasa
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados